David Luo

David Luo is a seasoned clinical operations executive with extensive experience in the biotechnology and pharmaceutical industries. As the Senior Vice President of Clinical Operations at Candid Therapeutics since July 2024, David has previously held senior leadership roles at Medikine, Inc. and Erasca, Inc., where responsibilities included overseeing clinical research and operations. David's background includes significant contributions to organizations such as Synthorx, Inc., IGNYTA, Inc., and Elevation Pharmaceuticals, with a focus on personalized medicine, drug/device combination therapies, and clinical study management across various therapeutic areas. Educational credentials include a Master of Public Health in Toxicology and Environmental Health Sciences from UCLA and a Bachelor of Science in Biology from UC San Diego.